DR. REHAN MOHAMMAD HUSSAIN (M.D,) – Ophthalmology Physician, NPI 1922340066
Ophthalmology Physician
Main info
Doctor Profile
Profile Insights
NPPES metrics only — not quality of care.
958 OPHTHALMOLOGY in IL
Provider Addresses for DR. REHAN MOHAMMAD HUSSAIN (M.D,)
133 E BRUSH HILL RD STE 300
ELMHURST, IL 601265659
Phone:
Type: Mailing
2799 W. Grand Boulevard
Henry Ford Hospital, Medical Edu
Detroit, MI 48202
Phone: (313) 916-2600
Type: Location
800 Austin St Ste 154
Evanston, IL 602023452
Phone: (847) 866-9700
Fax: (847) 866-8459
Type: Location
19900 Governors Dr Ste 104
Olympia Fields, IL 604611072
Phone: (708) 503-4176
Fax: (708) 503-4118
Type: Location
4700 W 95th St Ste Ll8
Oak Lawn, IL 604532593
Phone: (708) 499-4192
Fax: (708) 499-5674
Type: Location
1530 N RANDALL RD STE 202
ELGIN, IL 601237879
Phone: (847) 488-1030
Fax: (847) 488-0677
Type: Location
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 35 Open Payments records for all available years, with a total value of $8,288.
Total Amount is formed as General ($8,288) + Research ($0) + Ownership ($0) = $8,288.
Last reported payment date: 2024-12-04 • Largest payer in this snapshot: Regeneron Pharmaceuticals, Inc. ($4,869).
Total Amount
$8,288
General + Research + Ownership
Payments
35
Total payment records
General Amount
$8,288
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-12-04
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| Regeneron Pharmaceuticals, Inc. | $4,869 |
| EyePoint Pharmaceuticals US, Inc. | $1,938 |
| Astellas Pharma US Inc | $617 |
| Alimera Sciences, Inc. | $516 |
| Harrow Eye, LLC | $125 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
PECOS enrollment status
Participating (accepts Medicare assignment)
Enrollment effective: 2025-05-22
PECOS data refreshed: 2026-05-27
Medicare revalidation (CMS due date list)
Due date not assigned yet
CMS is tracking 2 Medicare enrollment records; no due dates published yet.
Enrollment records
2
Earliest due date
Not assigned (TBD)
CMS data updated
2026-06-01
Revalidation progress
- Medicare enrolled
- On CMS revalidation list
- Due date assigned
- Revalidate in PECOS
CMS enrollment records
| Enrollment ID | Type | Specialty | State | Due date |
|---|---|---|---|---|
| I20190724002608 | I | Ophthalmology | IL | TBD |
| I20250522003469 | I | Ophthalmology | OK | TBD |
What to do next
- No action required while the due date shows TBD.
- Check the CMS Revalidation Lookup Tool periodically — CMS updates the list about every 60 days.
- Do not submit a revalidation application in PECOS until CMS publishes a concrete due date.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 18,600 | 52 | $0 |
| 92134 | Imaging of retina | 2,611 | 829 | $0 |
| 67028 | Injection of drug into eye | 1,988 | 352 | $0 |
| J0178 | Injection, aflibercept, 1 mg | 1,686 | 144 | $0 |
| J9035 | Injection, bevacizumab, 10 mg | 1,088 | 235 | $0 |
Insurance plans in this area (ZIP 60126)
Loading plans...
Group practice members
| Name | Specialty | State |
|---|---|---|
| O P H T H A L M O L O G Y | IL | |
| O P H T H A L M O L O G Y | IL | |
| O P H T H A L M O L O G Y | IL | |
| O P H T H A L M O L O G Y | IL | |
| O P H T H A L M O L O G Y | IL |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.